Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

W C Shyu

Showing results (71-80 of 101) with videos related to

Pageof 11
Sort By:
Biopharmaceutics & Drug Disposition|July 1, 1993
Biopharmaceutical evaluation of transnasal, sublingual, and buccal disk dosage forms of butorphanolW C Shyu, R F Mayol, M Pfeffer, et al.
Neuropathology and Applied Neurobiology|October 21, 2019
Mechanisms of ischaemic neural progenitor proliferation: a regulatory role of the HIF-1α-CBX7 pathwayH-Y Chiu, H-T Lee, K-H Lee, et al.
Public Health Nursing (Boston, Mass.)|November 3, 1998
Consistency between preference and use of long-term care among caregivers of stroke survivorsL Chiu, K Y Tang, Y H Liu, et al.
Journal of Clinical Pharmacology|May 29, 1998
Lack of effect of food on the oral bioavailability of irbesartan in healthy male volunteersN N Vachharajani, W C Shyu, S Mantha, et al.
Journal of Clinical Pharmacology|September 1, 1992
Oral absolute bioavailability and intravenous dose-proportionality of cefprozil in humansW C Shyu, V R Shah, D A Campbell, et al.
Antimicrobial Agents and Chemotherapy|June 1, 1990
Comparison of cefprozil and cefaclor pharmacokinetics and tissue penetrationR H Barbhaiya, U A Shukla, C R Gleason, et al.
Antimicrobial Agents and Chemotherapy|February 1, 1990
Phase I study of single-dose BMY-28100, a new oral cephalosporinR H Barbhaiya, C R Gleason, W C Shyu, et al.
Journal of Clinical Pharmacology|September 2, 1998
Oral bioavailability and disposition characteristics of irbesartan, an angiotensin antagonist, in healthy volunteersN N Vachharajani, W C Shyu, T J Chando, et al.
Liver|October 1, 1990
DNA measurements in chronic hepatitis, cirrhosis and hepatocellular carcinomaH H Lin, W C Shyu, G L Chen, et al.
Antimicrobial Agents and Chemotherapy|September 1, 1994
Penetration of cefprozil into middle ear fluid of patients with otitis mediaW C Shyu, J Haddad, J Reilly, et al.
Pageof 11

Showing results (71-80 of 101) with videos related to

Sort By:
Pageof 11
Biopharmaceutics & Drug Disposition|July 1, 1993
Biopharmaceutical evaluation of transnasal, sublingual, and buccal disk dosage forms of butorphanolW C Shyu, R F Mayol, M Pfeffer, et al.
Neuropathology and Applied Neurobiology|October 21, 2019
Mechanisms of ischaemic neural progenitor proliferation: a regulatory role of the HIF-1α-CBX7 pathwayH-Y Chiu, H-T Lee, K-H Lee, et al.
Public Health Nursing (Boston, Mass.)|November 3, 1998
Consistency between preference and use of long-term care among caregivers of stroke survivorsL Chiu, K Y Tang, Y H Liu, et al.
Journal of Clinical Pharmacology|May 29, 1998
Lack of effect of food on the oral bioavailability of irbesartan in healthy male volunteersN N Vachharajani, W C Shyu, S Mantha, et al.
Journal of Clinical Pharmacology|September 1, 1992
Oral absolute bioavailability and intravenous dose-proportionality of cefprozil in humansW C Shyu, V R Shah, D A Campbell, et al.
Antimicrobial Agents and Chemotherapy|June 1, 1990
Comparison of cefprozil and cefaclor pharmacokinetics and tissue penetrationR H Barbhaiya, U A Shukla, C R Gleason, et al.
Antimicrobial Agents and Chemotherapy|February 1, 1990
Phase I study of single-dose BMY-28100, a new oral cephalosporinR H Barbhaiya, C R Gleason, W C Shyu, et al.
Journal of Clinical Pharmacology|September 2, 1998
Oral bioavailability and disposition characteristics of irbesartan, an angiotensin antagonist, in healthy volunteersN N Vachharajani, W C Shyu, T J Chando, et al.
Liver|October 1, 1990
DNA measurements in chronic hepatitis, cirrhosis and hepatocellular carcinomaH H Lin, W C Shyu, G L Chen, et al.
Antimicrobial Agents and Chemotherapy|September 1, 1994
Penetration of cefprozil into middle ear fluid of patients with otitis mediaW C Shyu, J Haddad, J Reilly, et al.
Pageof 11